Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.04B |
| 2 |
Gaotu Techedu
GOTU
|
+$1.03B |
| 3 |
Visa
V
|
+$749M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$517M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$515M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.43B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.58B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$759M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$643M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.23% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Healthcare | 7.67% |
| 4 | Financials | 7.46% |
| 5 | Communication Services | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
CALL
Seagate
STX
$184B
| $1.44M | ﹤0.01% |
23,200
-34,100
| -60% | -$1.92M |
|
3902
CALL
Agilent Technologies
A
$41.2B
| $1.43M | ﹤0.01% |
+12,100
| New | +$1.34M |
|
3903
CALL
Crown Castle
CCI
$32.2B
| $1.43M | ﹤0.01% |
9,000
-110,800
| -92% | -$18M |
|
|
XOMA
3904
DELISTED
Xoma
XOMA
| $1.43M | ﹤0.01% |
32,419
-11,212
| -26% | -$338K |
|
3905
Franklin Covey
FC
$246M
| $1.43M | ﹤0.01% |
64,144
-35,987
| -36% | -$748K |
|
3906
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $1.43M | ﹤0.01% |
51,022
+12,106
| +31% | +$339K |
|
|
SVOKU
3907
DELISTED
Seven Oaks Acquisition Corp. Unit
SVOKU
| $1.43M | ﹤0.01% |
+138,000
| New | +$1.43M |
|
3908
Argan
AGX
$8.37B
| $1.42M | ﹤0.01% |
31,983
-11,099
| -26% | -$498K |
|
3909
Elbit Systems
ESLT
$40.3B
| $1.42M | ﹤0.01% |
10,876
-16,942
| -61% | -$2.04M |
|
3910
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.4B
| $1.42M | ﹤0.01% |
25,870
+9,677
| +60% | +$500K |
|
|
GREK
3911
Global X MSCI Greece ETF
GREK
$316M
| $1.42M | ﹤0.01% |
+55,775
| New | +$1.23M |
|
3912
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.83B
| $1.42M | ﹤0.01% |
25,583
-49,766
| -66% | -$2.51M |
|
3913
Hudbay
HBM
$12.3B
| $1.42M | ﹤0.01% |
202,600
+161,000
| +387% | +$910K |
|
|
HTBK
3914
DELISTED
Heritage Commerce
HTBK
| $1.42M | ﹤0.01% |
159,585
+32,435
| +26% | +$263K |
|
3915
St. Joe Company
JOE
$3.83B
| $1.41M | ﹤0.01% |
33,276
-129,152
| -80% | -$4.11M |
|
3916
PUT
CRISPR Therapeutics
CRSP
$5.17B
| $1.41M | ﹤0.01% |
+9,200
| New | +$1.09M |
|
3917
Anterix
ATEX
$1.94B
| $1.4M | ﹤0.01% |
37,306
-6,237
| -14% | -$206K |
|
|
NFBK
3918
DELISTED
Northfield Bancorp
NFBK
| $1.4M | ﹤0.01% |
113,755
-107,046
| -48% | -$1.19M |
|
3919
PUT
Madrigal Pharmaceuticals
MDGL
$11.8B
| $1.4M | ﹤0.01% |
12,600
-10,000
| -44% | -$1.22M |
|
3920
Methanex
MEOH
$4.12B
| $1.4M | ﹤0.01% |
30,350
-185,700
| -86% | -$6.69M |
|
3921
York Water
YORW
$514M
| $1.4M | ﹤0.01% |
29,972
+687
| +2% | +$31.4K |
|
3922
Advantage Solutions
ADV
$361M
| $1.39M | ﹤0.01% |
+4,234
| New | +$1.11M |
|
3923
TherapeuticsMD
TXMD
$24M
| $1.39M | ﹤0.01% |
23,016
-18,819
| -45% | -$1.28M |
|
|
ACB
3924
Aurora Cannabis
ACB
$185M
| $1.39M | ﹤0.01% |
16,753
+3,214
| +24% | +$234K |
|
|
HBI
3925
PUT
DELISTED
Hanesbrands
HBI
| $1.39M | ﹤0.01% |
95,400
| – | – |
|
Similar funds
Goldman Sachs's Q4 2020 Portfolio in Review
As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.
- Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
- Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
- Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
- Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
- Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
- Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
- Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.